The biology graph.
Most biology is unsolved. Most of the biology that is solved, is solved in the wrong species. What we understand was mostly learned in humans or a handful of lab species, not the thousands of animals a veterinarian treats. Animal medicine is where the next layer of biological infrastructure gets built. The substrate is open, the data is unclaimed, and the work matters on its own terms.
Human and animal medicine are asymmetric.
Human medicine operates on a single species, with centuries of standardized protocols, unified databases, regulatory clarity, and a generation of AI tooling already arriving.
Animal medicine operates on thousands of species. The clinical record is fragmented. The literature is scattered. The regulatory frame is open in ways that human medicine's no longer is: no HIPAA, no FDA approval cycle for clinical software, no insurance gatekeeping. There is no incumbent at the substrate layer. The window is open now.
Four products that compound into a biology infrastructure company.
The reasoning engine. The longitudinal record. The named-specialist team. The outcome loop that closes between clinic and home.
Each is a defensible product on its own. Together they compound into something singular: a structured, longitudinal, multi-species clinical record with named clinicians behind it, that grows more valuable with every case.
The collective intelligence surface. Structured, cited, species-aware. Every answer auditable.
Longitudinal medical record per animal. Travels with the patient. Owned by the clinic and the owner.
Named board-certified specialists behind every room. The system never extrapolates past where they've signed off.
OpenAnimal closes the clinic-to-home circuit. Owners report outcomes. The record gets smarter case by case.
Four products. One substrate.
What the substrate produces.
A structured, longitudinal, multi-species clinical record is not only a veterinary asset. It is a biology asset.
Dogs age roughly seven times faster than humans. The closed outcome loop produces clinical-grade feedback on a timescale no other medical system can match. A treatment thesis that would take fifteen years to validate elsewhere can be validated in a fraction of the time.
Every case, every outcome, every cross-species pattern is a token the public literature does not contain. The corpus is the substrate for the next generation of animal-medicine intelligence.
Animal medicine is the work. It matters on its own terms.
Why now.
Three conditions had to coincide. Foundation models capable of real clinical reasoning, not just summarization. A veterinary workforce squeezed by consolidation and a generational cost crisis. A regulatory frame that leaves the substrate layer to a private builder.
All three are present, simultaneously, for the first time. The window will not stay this open.